A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients

NCT01328093 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
678
Enrollment
INDUSTRY
Sponsor class

Stopped The decision to stop the trial was based on efficacy results in the overall schizophrenia participant population.

Conditions

Interventions

Sponsor

Denovo Biopharma LLC